Pharmaceutical use of forskolin derivatives
    1.
    发明授权
    Pharmaceutical use of forskolin derivatives 失效
    福斯高林衍生物的药用

    公开(公告)号:US5789439A

    公开(公告)日:1998-08-04

    申请号:US861262

    申请日:1997-05-21

    IPC分类号: A61K31/35 A61K31/352

    CPC分类号: A61K31/352 A61K31/35

    摘要: The present invention relates to novel pharmaceutical use of forskolin derivatives represented by the general formula: ##STR1## wherein R.sup.1, R.sup.2 and Ac are as defined later ##STR2## (wherein R.sup.3 and R.sup.4 are each hydrogen or lower alkyl group, or R.sup.3 and R.sup.4 may be combined to represent lower alkylene group which may have oxygen or nitrogen atom in the linking chain, and n is an integer of 1 to 5); R.sup.2 represents hydrocarbon group having 2 to 3 carbon atoms; and Ac represents acetyl group. The above-mentioned forskolin derivative or a physiologically acceptable salt thereof can be used as a platelet aggregation inhibiting or controlling agent, spasmolytic agent, therapeutic agent for skin ulcer, peripheral circulation improving agent for limbs and differentiation inducing and promoting agent.

    摘要翻译: 本发明涉及由以下通式表示的毛喉素衍生物的新型药物用途:其中R1,R2和Ac如下文定义(其中R3和R4各自为氢或低级烷基,或R3和R4 可以结合表示在连接链中可以具有氧或氮原子的低级亚烷基,n是1〜5的整数); R2表示碳原子数2〜3的烃基, Ac表示乙酰基。 上述的毛喉素衍生物或其生理上可接受的盐可以用作血小板聚集抑制剂,解痉药,皮肤溃疡治疗剂,肢体周边循环改善剂和分化诱导促进剂。